Clin Gastroenterol Hepatol March 2017 PMID 27523634

Suspected Nonceliac Gluten Sensitivity Confirmed in Few Patients After Gluten Challenge in Double-Blind, Placebo-Controlled Trials.

Javier Molina-Infante, Antonio Carroccio

Download social card

Mentions

36
Peak: 1 in Aug 2021
across 5 sources since Aug 2021

Extended reach

12,732
potential audience

Total likes

1,281

Video views

12,725

Mentions per month

Aug 2021 – Sep 2025

Where it's discussed

  • News16 articles
  • Facebook15 posts
  • YouTube2 videos
  • Blogs2 articles
  • Bluesky1 posts

AI synopsis

What people are saying

Discussions emphasize that many people claiming nonceliac gluten sensitivity may not actually be affected, citing studies like pubmed.ncbi.nlm.nih.gov/27523634/. The tone balances scientific critique with considerations of diet choices, highlighting that gluten-free options are often not healthier and can be more expensive, which reflects a nuanced reflection on health impacts and societal perceptions.

AgreementModerate agreement

The discussions reflect general agreement that many individuals claiming gluten sensitivity may not actually be affected, supported by references to blinded studies and existing research.

InterestModerate interest

Participants show moderate interest by referencing specific studies and discussing the health and economic implications of a gluten-free diet.

EngagementModerate engagement

Some posts engage with the scientific evidence and broader health implications, indicating a moderate level of thoughtful discussion.

ImpactNeutral impact

While the discussion acknowledges the importance of proper diagnosis, the overall influence of these posts on public perceptions remains limited.

Abstract in brief

  • Double-blind placebo-controlled gluten challenges are used to diagnose nonceliac gluten sensitivity (NCGS) by observing symptom responses after gluten intake.
  • In a review of 10 studies involving 1312 adults, only 16% of NCGS patients showed gluten-specific symptoms, and many experienced nocebo effects, with symptoms also appearing during placebo.
  • These findings suggest that gluten may not be the primary cause of symptoms in most suspected NCGS cases, and methodological issues, including the nocebo effect, complicate diagnosis.

Top posts

Most liked on X and Bluesky
Timothy Caulfield
@caulfieldtim.bsky.social · Bluesky

Yep, some may be NCGS (the etc), but % low. Blinded studies have found people who think they sensitive aren't (e.g., pubmed.ncbi.nlm.nih.gov/27523634/ pubmed.ncbi.nlm.nih.gov/29542844/ ) The point: gluten-free ain't inherently healthier. More expensive. Less nutritious. www.cbc.ca/news/canada/...

Sep 12, 2025 · 7 likes · 4 shares View post →

All mentions

Timothy Caulfield
@caulfieldtim.bsky.social · Bluesky

Yep, some may be NCGS (the etc), but % low. Blinded studies have found people who think they sensitive aren't (e.g., pubmed.ncbi.nlm.nih.gov/27523634/ pubmed.ncbi.nlm.nih.gov/29542844/ ) The point: gluten-free ain't inherently healthier. More expensive. Less nutritious. www.cbc.ca/news/canada/...

Sep 12, 2025 · 7 likes · 4 shares View post →